References
Noris M, Remuzzi G. Thrombotic microangiopathy after kidney transplantation. Am J Transpl. 2010;10:1517–23.
Zuber J, Le Quintrec M, Morris H, Fremeaux-Bacchi V, Loirat C, Legendre C. Targed strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. Transpl Rev (Orland). 2013;27:117–25.
Ikeda T, Okumi M, Unagami K, Kanzawa T, Sawada A, Kawanishi K, et al. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab. Nephrology (Carlton). 2016;21(Suppl 1):35–40.
Le Quintrec M, Zubar J, Moulin B, Kamar N, Jablonski M, Lionet A, et al. Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am J Transpl. 2013;13:663–75.
Nadasdy T. Thrombotic microangiopathy in renal allografts: the diagnostic challenge. Curr Opin Organ Transpl. 2014;19:283–92.
Funding
No financial and material support was received for this work.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
About this article
Cite this article
Satoh, S., Saito, K., Harada, H. et al. Survey of thrombotic microangiopathy within 1 week after kidney transplantation between 2010 and 2015 in Japan. Clin Exp Nephrol 23, 571–572 (2019). https://doi.org/10.1007/s10157-018-1655-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-018-1655-2